Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States) (original) (raw)
Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH (2001) Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92:549–555 ArticlePubMedCAS Google Scholar
Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29:645–654 ArticlePubMedCAS Google Scholar
Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049–2053 ArticlePubMedCAS Google Scholar
El-Serag HB, Mason AC, Petersen N, Key CR (2002) Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 50:368–372 ArticlePubMedCAS Google Scholar
Eloubeidi MA, Mason AC, Desmond RA, El-Serag HB (2003) Temporal trends (1973–1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol 98:1627–1633 PubMed Google Scholar
Nguyen AM, Luke CG, Roder D (2003) Comparative epidemiological characteristics of oesophageal adenocarcinoma and other cancers of the oesophagus and gastric cardia. Asian Pac J Cancer Prev 4:225–231 PubMed Google Scholar
Vizcaino AP, Moreno V, Lambert R, Parkin DM (2002) Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer 99:860–868 ArticlePubMedCAS Google Scholar
Younes M, Henson DE, Ertan A, Miller CC (2002) Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol 37:1359–1365 ArticlePubMedCAS Google Scholar
Vaughan TL (2002) Esophagus. In: Franco EL, Rohan TE (eds) Cancer precursors. Springer-Verlag New York, Inc., pp 69–116
Kim R, Weissfeld JL, Reynolds JC, Kuller LH (1997) Etiology of Barrett’s metaplasia and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 6:369–377 PubMedCAS Google Scholar
Ramel S (2003) Barrett’s esophagus:model of neoplastic progression. World J Surg 27:1009–1013 ArticlePubMed Google Scholar
Reid BJ (1991) Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am 20:817–834 CAS Google Scholar
Shaheen N, Ransohoff DF (2002) Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications. JAMA 287:1972–1981 ArticlePubMed Google Scholar
Vaughan TL, Kristal AR, Blount PL, et al (2002) Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 11:745–752 PubMed Google Scholar
Whittles CE, Biddlestone LR, Burton A, et al (1999) Apoptotic and proliferative activity in the neoplastic progression of Barrett’s oesophagus:a comparative study. J Pathol 187:535–540 ArticlePubMedCAS Google Scholar
Wild CP, Hardie LJ (2003) Reflux, Barrett’s oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 3:676–684 ArticlePubMedCAS Google Scholar
Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA (1990) Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 99:918–922 PubMedCAS Google Scholar
Wang LD, Zheng S, Zheng ZY, Casson AG (2003) Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol 9:1156–1164 PubMed Google Scholar
Powell J, McConkey CC, Gillison EW, Spychal RT (2002) Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer 102:422–427 ArticlePubMedCAS Google Scholar
Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW (1999) Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg 86:529–535 ArticlePubMedCAS Google Scholar
Corley DA, Buffler PA (2001) Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the cancer incidence in five continents database. Int J Epidemiol 30:1415–1425 ArticlePubMedCAS Google Scholar
Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database:Incidence – SEER Regs Public-Use, Nov 2002 Sub (1973–2000), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission
Holford TR (1991) Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 12:425–457 ArticlePubMedCAS Google Scholar
Kupper LL, Janis JM, Karmous A, Greenberg BG (1985) Statistical age–period–cohort analysis: a review and critique. J Chronic Dis 38:811–830 ArticlePubMedCAS Google Scholar
Zheng T, Mayne ST, Holford TR, et al (1992) Time trend and age–period–cohort effects on incidence of esophageal cancer in Connecticut, 1935–89. Cancer Causes Control 3:481–492 ArticlePubMedCAS Google Scholar
Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: Age–period and age–cohort models. Stat Med 6:449–467 PubMedCAS Google Scholar
Holford TR (1992) Analysing the temporal effects of age, period and cohort. Stat Methods Med Res 1:317–337 PubMedCAS Google Scholar
Luebeck EG, Moolgavkar SH (2002) Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci USA 99:15095–15100 ArticlePubMedCAS Google Scholar
Cameron AJ, Lomboy CT (1992) Barrett’s esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 103:1241–1245 PubMedCAS Google Scholar
Wong DJ, Paulson TG, Prevo LJ, et al (2001) p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett’s metaplastic epithelium. Cancer Res 61:8284–8289 PubMedCAS Google Scholar
Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG, Reid BJ (2004) Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett’s esophagus. Cancer Res 64:3414–3427 ArticlePubMedCAS Google Scholar
Heidenreich WF, Luebeck EG, Moolgavkar SH (1997) Some properties of the hazard function of the two-mutation clonal expansion model. Risk Anal 17:391–399 ArticlePubMedCAS Google Scholar
Mayne ST, Navarro SA (2002) Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. J Nutr 132:3467S–3470S PubMedCAS Google Scholar
Herbst JJ, Berenson MM, McCloskey DW, Wiser WC (1978) Cell proliferation in esophageal columnar epithelium (Barrett’s esophagus). Gastroenterology 75:683–687 PubMedCAS Google Scholar
Uys P, van Helden PD (2003) On the nature of genetic changes required for the development of esophageal cancer. Mol Carcinog 36:82–89 ArticlePubMedCAS Google Scholar
Maley CC, Galipeau PC, Li X, et al (2004) The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res 64:7629–7633 ArticlePubMedCAS Google Scholar
Cameron AJ, Arora AS (2002) Barrett’s esophagus and reflux esophagitis: is there a missing link? Am J Gastroenterol 97:273–278 ArticlePubMed Google Scholar
Farrow DC, Vaughan TL, Sweeney C et al (2000) Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 11:231–238 ArticlePubMedCAS Google Scholar
Cameron AJ (2002) Epidemiology of Barrett’s esophagus and adenocarcinoma. Dis Esophagus 15:106–108 ArticlePubMedCAS Google Scholar
Pohl H, Welch HG (2005) The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97:142–146 ArticlePubMed Google Scholar
Lagergren J (2005) Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? Gut 54(Suppl 1):1–5 Article Google Scholar
Engel LS, Chow W, Vaughan TL, et al (2003) Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404–1413 PubMed Google Scholar
Cameron AJ, Welborn TA, Zimmet PZ, et al (2003) Overweight and obesity in Australia:the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 178:427–432 PubMed Google Scholar
La Vecchia C, Negri E, Lagiou P, Trichopoulos D (2002) Oesophageal adenocarcinoma: a paradigm of mechanical carcinogenesis? Int J Cancer 102:269–270 ArticlePubMedCAS Google Scholar
Barrett MT, Sanchez CA, Prevo LJ, et al (1999) Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 22:106–109 ArticlePubMedCAS Google Scholar
Maley CC, Galipeau PC, Li X, Sanchez CA, Paulson TG, Reid BJ (2004) Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett’s esophagus. Cancer Res 64:3414–3427 ArticlePubMedCAS Google Scholar
Shaheen NJ, Inadomi JM, Overholt BF, Sharma P (2004) What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis. Gut 53:1736–1744 ArticlePubMedCAS Google Scholar
Spechler SJ, Barr H (2004) Review article: screening and surveillance of Barrett’s oesophagus: what is a cost-effective framework? Aliment Pharmacol Ther 19(Suppl 1):49–53 ArticlePubMed Google Scholar
Vaughan TL, Dong LM, Blount PL, et al (2005) Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett’s oesophagus: a prospective study. Lancet Oncol 6:945–952 ArticlePubMedCAS Google Scholar